Introduction {#Sec1}
============

Premature ventricular contraction (PVC) is the most common cardiac arrhythmia in patients with or without any kind of diagnosed cardiac diseases^[@CR1]^. Catheter ablation is an effective therapy in the treatment of frequent PVC or ventricular tachycardia (VT). Before the advancement of cardiac mapping techniques, the origin of ventricular arrhythmia (VA) was a matter of interest but lacked relevance. When therapeutic options became available, mapping tools to locate areas responsible for arrhythmias became important. By using the mapping tool, the electrophysiologist could correlate the surface electrocardiogram (ECG) of the VA with the area in the heart at which ablation could eradicate it.

Previous study demonstrated that the reverse splitting second heart sound (S2), which required additional carotid pressure tracing tool, was associated with the origin of ectopies^[@CR2]^. Transesophageal echocardiography Tissue Doppler also provided an alternative method to identify the earliest onset of myocardial excitation in the animal study^[@CR3]^. However, the application of these invasive tools was not clinically practical but only reserved for study with special facility. There is no other well-validated tool to identify the origin of ventricular arrhythmia currently. The ECG still remains the simplest and cost effective non-invasive diagnostic method for determining origin of VA^[@CR4]^. It is useful to localize the site of origin of VA before intervention to facilitate catheter ablation^[@CR5]^. Although many ECG criteria using the vectors from 12 lead recordingscan predict VA origin, it is limited by the need to record a 12-lead surface ECG with recording of PVC. Holter monitoring with fewer leads or a single lead strip is unable to predict VA origin due to the limited information from fewer vectors.

Burggraf^[@CR6]^ studied 26 left bundle branch block (LBBB) subjects and 20 normal subjects with phonocardiogram using Cambridge microphones and a Cambridge fiberoptic multichannel physiologic recorder. With LBBB the first heart sound (S1) tended to be of reduced intensity and separate mitral and tricuspid components could not be identified. Brooks *et al*.^[@CR7]^ studied 20 right bundle branch block (RBBB) subjects and 67 normal subjects with simultaneous echocardiogram of valves, electrocardiogram, and phonocardiogram. Wide splitting of the S1 was observed in RBBB subjects^[@CR7],[@CR8]^. These studies demonstrated the wavefront of ventricular myocardial activation affect the timing of valvular closure, which could be detected and quantified by well-designed acoustic cardiography device.

Acoustic cardiography is a cost-effective technology, which incorporates hemodynamic information and electrocardiac signals for clinical assessment^[@CR9]^. Acoustic cardiography permits simultaneous acquisition of ECG and heart sound information and provides a computerized interpretation of these findings. Although, the application of heart sounds in prediction of the origin of VA has been intensively investigated, it is not clinically available because of the lack of objectivity^[@CR2],[@CR10],[@CR11]^. The present study was designed to test whether acoustic cardiography could provide information in differentiating the origin of VA in clinical practice.

Methodology {#Sec2}
===========

Study participants {#Sec3}
------------------

This was a retrospective, single center cohort study. From January 2015 to June 2017, 45 patients (31 men \[68.9%\], mean age 59 ± 17 years old) undergoing catheter ablation of monoform VA with contemporaneous digital acoustic cardiography were enrolled. All patients routinely underwent transthoracic two-dimensional echocardiogram and 12 lead ECG. Exclusion criteria included the echocardiographic determination of heart failure (HF) and valvular heart disease due to possible acoustic abnormalities. Patients with chronic lung diseases and obesity were also excluded, as abnormalities of pulmonary function may confound the transmission of acoustic signals. Patients were also excluded if complete RBBB or LBBB was observed (QRS duration \>120 ms)^[@CR12]^.

Patients were classified into two groups (Group 1, ventricular ectopic beats from right ventricle \[RV\]; Group 2, ventricular ectopic beats from left ventricle \[LV\]) based on electrophysiological study and three-dimensional electroanatomic mapping. VAs from outflow tract (OT) was documented in 15 (62.5%) patients within Group 1 and 11 (52.4%) patients within Group 2.

Institutional Review Board at Taipei Veterans General Hospital, Taipei, Taiwan approved this study without requiring patients' informed consent (VGH-IRB Number: 2014-09-012A). All patients signed their written informed consent according to the institutional guidelines of the Taipei Veterans General Hospital. All methods were performed in accordance with the relevant guidelines and regulations.

Acoustic cardiography {#Sec4}
---------------------

Each subject underwent the acoustic cardiographic examination before the electrophysoplogical study (AUDICOR, Inovise Medical, Inc., Portland, OR, USA). Acoustic cardiographic raw data were transferred to Inovise Medical and were analyzed by the computerized algorithm for the measurement of heart sound parameters and systolic time intervals. This algorithm has been validated by blinded interpretation of heart sound tracings by experts, and the relationship of these variables to hemodynamic measurements obtained by invasive and non-invasive methods has been previously reported^[@CR13]--[@CR15]^.

Three acoustic cardiographic characteristics of S1 and S2 were analyzed: intensity, complexity, and splitting duration. A value for heart sound intensity is generated based on the peak-to-peak amplitude of the sound and expressed in mV units. Heart sound complexity is a correlate of the auditory perception of valve sound crispness and is determined using time-frequency measures of width, intensity and frequency content of the signal, which is influenced by valve splitting or closure abnormalities. Based on spectral analysis, complexity is expressed as a dimensionless index. Splitting duration was measured by the algorithm from the onset to the end of the heart sound. (Figs [1](#Fig1){ref-type="fig"}--[3A](#Fig3){ref-type="fig"}) Electromechanical activation time (EMAT) represents the time from the Q wave onset to the mitral component of the S1. EMAT reflects the time required for LV to generate sufficient force to close the mitral valve. The average acoustic cardiographic parameters were retrieved from the sinus rhythm (SR) beats and PVC beats separately. Wide QRS beats with different QRS morphology (compared to the dominant PVC) was excluded for analysis manually.Figure 1Example of acoustic cardiographic output and electroanatomic mapping in a Group 1 patient with non-outflow tract RV VA. (**A**) Acoustic cardiographic output including ECG, 2- and 3-D display of time-frequency information. The PVC S1 splitting duration and complexity were smaller than SR beats. (**B**) 3-D electroanatomic mapping with pacemapping shows a high similarity of QRS morphology located at the right ventricular basal area (red color) where catheter ablation successfully terminated the VA. 3-D, three-dimensional; ECG, electrocardiography; PVC, premature ventricular complex; SR, sinus rhythm; VA, ventricular arrhythmia. Figure 2Example of acoustic cardiographic output and electroanatomic mapping of a Group 2 patient with non-outflow tract LV VA. (**A**) Acoustic cardiographic output including ECG, 2- and 3-D display of time-frequency information. The PVC S1 splitting duration and complexity were smaller than SR beats. (**B**) 3-D electroanatomic mapping with activation map shows that the earliest activation site of VA was located at the left ventricular septum area where pacemapping showed a good correlation and catheter ablation successfully terminated the VA. 3-D, three-dimensional; ECG, electrocardiography; LV, left ventricular; PVC, premature ventricular complex; SR, sinus rhythm; VA, ventricular arrhythmia. Figure 3Example of acoustic cardiographic output and electroanatomic mapping of a Group 1 patient with RVOT VA. (**A**) Acoustic cardiographic output including ECG, 2- and 3-D display of time-frequency information. The PVC S1 splitting duration and complexity were smaller than SR beats. (**B**) 3-D electroanatomic mapping with activation map shows that the earliest activation site of the VA was located at the RVOT septum area where catheter ablation successfully terminated the VA. 3-D, three-dimensional; ECG, electrocardiography; PVC, premature ventricular complex; SR, sinus rhythm; RVOT, right ventricular outflow tract; VA, ventricular arrhythmia. 3-D, three-dimensional; PVC, premature ventricular complex; SR, sinus rhythm; RVOT, right ventricular outflow tract; VA, ventricular arrhythmia.

Electrophysiological study, mapping, and radiofrequency catheter ablation {#Sec5}
-------------------------------------------------------------------------

All patients previously failed treatment with at least one antiarrhythmic drug. Anti-arrhythmic drugs were discontinued for a minimum of five half-lives before radio-frequency catheter ablation (except for amiodarone). After obtaining informed consent from the patients, we performed standardized electrophysiological study in the fasting non-sedated state for the endocardial procedure and the sedated condition for epicardial approaches, respectively. In the absence of spontaneous VA, rapid ventricular pacing and/or programmed stimulation of up to three extra-stimuli were performed from the RV apex and/or the RV outflow tract (RVOT). If the VAs were not inducible, intravenous isoprenaline at 1--5 μg/min was infused in order to achieve at least a 20% increment in the heart rate. If spontaneous VAs were not inducible during pharmacological provocation, the induction protocol was repeated. The QRS morphologies of spontaneous and/or induced VAs were compared with the clinically documented VAs.

The localization of the successful ablation focus was performed using a 3D mapping system (CARTO 3 V3.2.2 Software with the User Defined Map \[UDM\] feature, Biosense Webster \[Israel\], Diamond Bar, CA, USA). During the ablation procedure inside the LV, intravenous heparin was administered in order to maintain an activated clotting time of \>250 s. Pace mapping was performed in all cases using the distal bipolar electrodes at a pacing cycle length of 500 ms and stimulus amplitude of 1 mA greater than the late diastolic threshold up to a maximum output of 25 mA and pulse width of 4.0 ms. Activation mapping was intentionally performed in all cases in order to identify the earliest activation site. (Figs [1](#Fig1){ref-type="fig"}--[3B](#Fig3){ref-type="fig"}).

Radiofrequency energy was delivered via an irrigated tip catheter (Navistar Thermocool, Biosense Webster, Inc., Diamond Bar, CA, USA) with a maximal power of 30--40 watts, while targeting an impedance drop of 10 Ohms, maintained for a minimum of 120 s at the site of termination or elimination in VA. Once the VA was suppressed within 30 s, additional energy was applied up to a maximum of 5 burns, followed by substrate modification of the nearby abnormal potentials, including isolated or fractionated late potentials, if present. Acute procedural success was defined as complete elimination of spontaneous or inducible VAs under the infusion of isoprenaline (up to 5 μg/min), following the same induction protocol for 30 min in order to exclude acute recurrences.

Follow-up {#Sec6}
---------

Patients were followed up in the cardiology outpatient clinic with 12-lead ECGs, 24-hour Holter, monitoring, and echocardiography after the catheter ablation every 3 months for the first year, and then 6 months thereafter. For patients who could not come for outpatient follow up in our institution, they were contacted over the telephone for recurrent symptoms and recurrent arrhythmias. They were advised to visit our affiliated institutions to complete the follow-up screening, and transfer the data to the main hospital. The medical reports were obtained from those affiliated institutions. Recurrence was defined by recurrences of sustained VTs, nonsustained VTs, or greater than 1000 ventricular PVCs, as confirmed by the morphology criteria using the 24-hour Holter ECG.

Statistical analysis {#Sec7}
--------------------

All analyses were performed using SPSS statistical software, version 20.0 (IBM Corporation, USA). Continuous data are expressed as mean standard deviation and as percentages for categorical variables. All continuous data were tested using the 1-sample Kolmogorov-Smirnov test against a normal distribution. Continuous variables were compared using the independent Student t test. For comparison of dichotomous variables, the chi-square test was used. A p value of \< 0.05 was considered statistically significant. Receiver operator characteristic curves (ROC) and areas under the receiver operator characteristic curves were analyzed for the significant parameters to determine the optimal cut-off point for VA origin (Youden index).

Results {#Sec8}
=======

Study participants {#Sec9}
------------------

The baseline characteristics of these patients are presented in the Table [1](#Tab1){ref-type="table"}. Both groups were similar in baseline characteristics, including age, gender, medications, and clinical presentation.Table 1Baseline characteristics.Group 1Group 2P valueNumber2421Age, year59 ± 1961 ± 150.686Gender, male16 (66.7)15 (71.4)0.759Underlying disease Coronary artery disease5 (20.8)3 (14.3)0.705 ICD implantation4 (16.7)3 (14.3)0.999 Thyroid disease0 (0.0)3 (14.3)0.094 Hypertension9 (37.5)9 (42.9)0.767 Diabetes mellitus3 (12.5)4 (19.0)0.689 Heart failure3 (12.5)6 (28.6)0.267 Dyslipidemia7 (29.2)6 (28.6)0.999Symptom Dyspnea4 (16.7)2 (9.5)0.999 Palpitation24 (100.0)19 (90.5)0.212VA characteristics Clinical VT3 (12.5)5 (23.8)0.443 Clinical PVC21 (87.5)16 (76.2.5)0.443 OT origin15 (62.5)11 (52.4)0.555Medication Anti-platelet8 (33.3)9 (42.9)0.502 Beta-blocker11 (45.8)11 (52.4)0.768 Calcium channel blocker2 (8.3)6 (28.6)0.121 Propafenone4 (16.7)0 (0.0)0.111 Flecainide5 (20.8)2 (9.5)0.705 Amiodarone4 (16.7)6 (28.6)0.476 Mexitil6 (25.0)1 (4.8)0.101 ACEI or ARB5 (20.8)4 (19.0)0.884 Nitrite3 (12.5)0 (0.0)0.236 Aldactone0 (0.0)2 (9.5)0.212ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; OT, outflow tract; PVC, premature ventricular complex; ICD, implantable cardioverter defibrillator; VA, ventricular arrhythmia; VT, ventricular tachycardia.

Acoustic cardiography measurements of Group 1 and Group 2 {#Sec10}
---------------------------------------------------------

There was no significant difference in acoustic cardiographic measurement of sinus beats between Group 1 and Group 2 (Table [2](#Tab2){ref-type="table"}). Group 2 patients with VA from LV exhibited greater S1 splitting duration in comparison to Group 1 patients with VA from RV (S1 duration: 156.74 ± 28.56 vs 204.38 ± 32.49 ms, p \< 0.001). The subtracted acoustic cardiographic parameters were also obtained for further analysis (PVC-SR). Group 1 patients exhibited a negative change in S1 (ΔS1) complexity and S1 duration during ventricular beats compared to SR beats. On the other hand, Group 2 patients exhibited a positive change in S1 complexity and S1 duration during ventricular beats compared to SR beats. (−0.49 ± 1.20 vs. 0.69 ± 1.24, p = 0.003 \[ΔS1 complexity percentage: −0.03 ± 0.36 vs. 0.15 ± 0.41, p = 0.127\]; ΔS1 duration: −18.66 ± 11.78 vs. 15.27 ± 6.80ms, p \< 0.001 \[ΔS1 duration percentage: −0.09 ± 0.05 vs. 0.08 ± 0.42, p \< 0.001\]).Table 2Acoustic cardiography measurements.Group 1Group 2P valueNumber2421SR beat S1 intensity10.70 ± 6.668.90 ± 5.560.333 S1 complexity3.67 ± 1.183.42 ± 0.610.390 S1 duration182.82 ± 22.94189.22 ± 29.930.422 S2 intensity5.19 ± 2.864.55 ± 1.910.393 S2 complexity1.96 ± 0.692.44 ± 1.110.086 S2 duration107.80 ± 13.63107.74 ± 20.880.992 EMAT94.91 ± 14.50101.65 ± 14.740.130PVC beat S1 intensity8.51 ± 5.809.21 ± 5.280.689 S1 complexity3.39 ± 1.023.79 ± 1.230.216 S1 duration156.74 ± 28.56204.38 ± 32.49\<0.001 S2 intensity5.74 ± 5.505.42 ± 3.830.834 S2 complexity2.07 ± 1.971.96 ± 0.770.827 S2 duration85.84 ± 21.1489.83 ± 34.990.646 EMAT132.94 ± 21.22136.97 ± 28.860.611PVC -- SR beat and \[PVC -- SR beat\]/SR beat (% of change) S1 intensity−2.10 ± 5.25−0.09 ± 4.170.173  *% of change*−0.04 ± 0.550.12 ± 0.500.323 S1 complexity−0.49 ± 1.200.69 ± 1.240.003  *% of change*−0.03 ± 0.360.15 ± 0.410.127 S1 duration−18.66 ± 11.7815.27 ± 6.80\<0.001  *% of change*−0.14 ± 0.130.08 ± 0.36\<0.001 S2 intensity−0.50 ± 1.240.69 ± 1.240.923  *% of change*−0.19 ± 1.130.27 ± 1.130.835 S2 complexity−0.18 ± 1.83−0.58 ± 1.690.190  *% of change*−0.03 ± 0.78−0.09 ± 0.440.585 S2 duration−20.38 ± 20.03−19.46 ± 32.400.912  *% of change*−0.20 ± 0.19−0.17 ± 0.260.694EMAT, electromechanical activation time; PVC, premature ventricular complex; S1, first heart sound; S2, second heart sound; SR, sinus rhythm.

Acoustic cardiography measurements of OT VAs or non-OT VAs {#Sec11}
----------------------------------------------------------

The details of acoustic parameters between OT VAs and non-OT VAs are shown in Table [3](#Tab3){ref-type="table"}. In the patients with LV origin VAs, there was no significant difference in acoustic cardiographic measurement of SR, PVC between OT-VAs and non-OT VAs.Table 3Acoustic cardiography measurements (OT vs. non-OT).LV bodyLVOTP valueRV bodyRVOTP valueNumber1011915***SR beat***S1 intensity7.91 ± 3.909.79 ± 6.760.45114.16 ± 9.608.63 ± 3.520.056S1 complexity3.64 ± 0.363.21 ± 0.720.1083.39 ± 1.713.83 ± 0.740.398S1 duration183.90 ± 23.31194.06 ± 32.330.451172.68 ± 25.95188.11 ± 18.110.102S2 intensity4.12 ± 1.194.95 ± 2.390.3324.99 ± 4.125.31 ± 1.920.801S2 complexity2.09 ± 0.692.74 ± 1.380.1811.64 ± 0.782.15 ± 0.570.115S2 duration111.93 ± 24.51103.93 ± 17.250.394101.35 ± 14.57110.46 ± 9.570.112EMAT96.55 ± 10.74106.01 ± 14.341.0599.07 ± 21.2592.42 ± 8.360.287***PVC beat***S1 intensity9.64 ± 5.848.93 ± 4.650.5768.61 ± 8.678.84 ± 2.950.946S1 complexity3.97 ± 1.453.63 ± 1.050.5492.91 ± 1.213.60 ± 0.740.097S1 duration199.76 ± 24.92208.58 ± 38.880.548143.03 ± 22.82161.57 ± 26.350.125S2 intensity4.94 ± 2.045.86 ± 5.020.6153.93 ± 2.596.69 ± 6.420.112S2 complexity1.87 ± 0.742.06 ± 0.840.6201.10 ± 1.572.65 ± 2.260.110S2 duration101.16 ± 40.6080.03 ± 23.160.16877.05 ± 15.9489.12 ± 19.850.236EMAT125.59 ± 21.49147.21 ± 37.770.104133.03 ± 26.12132.88 ± 18.250.988***PVC -- SR***S1 intensity1.20 ± 2.98−1.17 ± 4.090.012−5.55 ± 5.190.29 ± 3.900.007*% of change*0.05 ± 0.48−0.50 ± 0.440.104−2.14 ± 0.34−0.54 ± 0.600.504S1 complexity0.35 ± 1.511.00 ± 0.900.240−0.48 ± 1.04−0.23 ± 1.250.198*% of change*0.11 ± 0.420.19 ± 0.420.655−0.09 ± 0.31−0.02 ± 0.380.184S1 duration15.97 ± 5.9814.64 ± 7.710.667−29.65 ± 13.70−26.54 ± 10.860.605*% of change*−0.09 ± 0.03−0.08 ± 0.040.461−0.18 ± 0.16−0.11 ± 0.100.104S2 intensity0.58 ± 2.390.72 ± 5.300.945−1.06 ± 4.011.38 ± 6.440.089*% of change*−0.20 ± 0.64−0.32 ± 1.470.823−0.24 ± 0.390.49 ± 1.380.104S2 complexity−0.27 ± 1.03−0.92 ± 2.260.445−0.54 ± 0.560.69 ± 2.230.123*% of change*−0.07 ± 0.37−0.11 ± 0.530.854−0.28 ± 0.470.22 ± 0.880.104S2 duration−9.95 ± 32.41−28.02 ± 31.530.235−24.30 ± 20.25−18.28 ± 19.610.358*% of change*−0.09 ± 0.25−0.25 ± 0.260.178−0.24 ± 0.20−0.18 ± 0.180.204EMAT, electromechanical activation time; LV, left ventricle; LVOT, left ventricular outflow tract; OT, outflow tract; PVC, premature ventricular complex; RV, right ventricle; RVOT, right ventricular outflow tract; S1, first heart sound; S2, second heart sound; SR, sinus rhythm.

In the patients with LV origin VAs, the subtracted acoustic cardiographic parameters (PVC-SR) in non-OT VAs exhibited a positive change in S1 intensity than that in the OT group (LV: non-OT vs OT: 1.20 ± 2.98 vs. −1.17 ± 4.09, *p* value = 0.012).

In the patients with RV origin VAs, the subtracted acoustic cardiographic parameters (PVC-SR) in non-OT VAs exhibited a negative change in S1 intensity than that in the OT group (LV: non-OT vs OT: −5.55 ± 5.19 vs. 0.29 ± 3.90, *p* value = 0.007).

Electrophysiological mapping and acoustic findings {#Sec12}
--------------------------------------------------

The PVC origins were confirmed by the electrophysiological mapping and successful ablation site. The localization of the successful ablation focus was performed using a 3-dimentional mapping system. Pace mapping and/or activation mapping were performed in order to identify the site of origin of the VA.

Radiofrequency energy was delivered via an irrigated tip catheter at the origin site of VA. Procedural success was defined as complete elimination of spontaneous or inducible VAs under the infusion of isoprenaline (up to 5 μg/min), following the same induction protocol for 30 min. Figures [1](#Fig1){ref-type="fig"}--[3](#Fig3){ref-type="fig"} shows examples of VA patient who received acoustic cardiography followed by catheter ablation. Acoustic cardiographic output including ECG, 2- and 3-dimensional display of time-frequency information. In the Group 1 patients, the PVC S1 splitting duration was smaller than SR beats (Figs [1A](#Fig1){ref-type="fig"} and [3A](#Fig3){ref-type="fig"}). Three- dimensional electroanatomic mapping and pacemapping showed that the PVCs exit were located at right lower free wall and RV outflow tract respectively (Figs [1B](#Fig1){ref-type="fig"} and [3B](#Fig3){ref-type="fig"}). In the Group 2 patients, the PVC S1 splitting duration was longer than SR beats (Fig. [2A](#Fig2){ref-type="fig"}). Three-dimensional electroanatomic mapping and pacemapping showed the PVC exit was located at LV septum (Fig. [2B](#Fig2){ref-type="fig"}). PVCs were eliminated successfully by catheter ablation.

Value of quantitative acoustic variables for the detection of VAs origins {#Sec13}
-------------------------------------------------------------------------

We investigated the value of PVC S1 duration, ΔS1 complexity, and ΔS1 duration for the detection of VA origin (right side or left side) by constructing ROC curves to assess the predictive performance. As shown in Fig. [4](#Fig4){ref-type="fig"} the area under ROC curve for PVC S1 duration, ΔS1 complexity, and ΔS1 duration was 0.508, 0.768, and 1.00 respectively. The optimal cut-offs of PVC S1 duration, ΔS1 complexity, and ΔS1 duration for the discrimination of VA origin was 174.8 ms (sensitivity 79.2%, specificity 42.9%), 0.13 (sensitivity 71.4%, specificity 75.0%) and −1.28 ms (sensitivity 100.0%, specificity 100.0%) respectively.Figure 4Scatter plots, Box plots, and ROC curve. (**A**) Box plot and scatter plot demonstrating the differences and the distribution of PVC S1 Duration of patients with VA originating from different chambers. (**B**) The ROC curve analysis of the PVC S1 Duration for predicting the VAs origin. (**C**) Box plot and scatter plot demonstrating the differences and the distribution of \[PVC-SR\] S1 Complexiity of patients with VA originating from different chambers. (**D**) The ROC curve analysis of the \[PVC-SR\] S1 Complexiity for predicting the VAs origin. (**E**) Box plot and scatter plot demonstrating the differences and the distribution of \[PVC-SR\] S1 Duration of patients with VA originating from different chambers. (**F**) The ROC curve analysis of the \[PVC-SR\] S1 Duration for predicting the VAs origin. AUC, area under the curve of ROC; LV, left ventricle; PVC, premature ventricular complex; ROC, receiver operating characteristic curve; RV, right ventricle; S1, first heart sound; S2, second heart sound; SR, sinus rhythm; VA, ventricular arrhythmia. Box plot explanation: upper horizontal line of box, 75th percentile; lower horizontal line of box, 25th percentile; horizontal bar within box, median; upper horizontal bar outside box, 90thpercentile; lower horizontal bar outside box, 10th percentile.

Regarding the traditional ECG criteria used to discriminate origin of VA, 24 (100.0%) RV VAs were presented with LBBB morphology, 17 (81.0%) LV VAs were presented with RBBB morphology. Four (19.0%) LV VAs were presented with LBBB morphology with early precordial transition before V2. The overall sensitivity and specificity was inferior to ΔS1 duration in the present study.

OT-VA vs. non-OV VA in left ventricle and right ventricle {#Sec14}
---------------------------------------------------------

In the patients with LV VAs, we investigated the value of ΔS1 intensity for the detection of OT VAs by constructing ROC curves to assess the predictive performance. As shown in Fig. [5A](#Fig5){ref-type="fig"}, the area under ROC curve for ΔS1 intensity was 0.80. The optimal cut-off value was 0.50 with sensitivity 90.0%, specificity 72.7%.Figure 5ROC curve analysis for predicting the OT VAs or non-OT Vas. (**A**) The ROC curve analysis of the \[PVC-SR\] S1 intensity for predicting the area of origin in the left ventricle. (**B**) The ROC curve analysis of the \[PVC-SR\] S1 intensity for predicting the area of origin in the right ventricle. AUC, area under the curve of ROC; PVC, premature ventricular complex; ROC, receiver operating characteristic curve; S1, first heart sound; S2, second heart sound; SR, sinus rhythm; VA, ventricular arrhythmia.

In the patients with RV VAs, we also investigated the value of ΔS1 intensity for the detection of OT VAs by constructing ROC curves to assess the predictive performance. As shown in Fig. [5B](#Fig5){ref-type="fig"}, the area under ROC curve for ΔS1 intensity was 0.82. The optimal cut-off value for ΔS1 intensity was −6.46 (Sensitivity 100%, Specificity 55.6%).

Clinical follow-up {#Sec15}
------------------

After a median follow-up of 16 ± 6 months (range 3 to 32 months), VA recurrences were documented in 4 patients (8.9%) after a mean follow-up of 7.5 (4--14) months. There was no statistical significance in the VA recurrences between the two groups (1 in Group 1 and 3 in Group 2, P value = 0.234). The QRS morphology of recurrent VA was similar to that before the catheter ablation in the 4 patients and repeated catheter ablation at the similar location eliminated the recurred VA smoothly.

Discussion {#Sec16}
==========

Acoustic profiles and ventricular ectopies {#Sec17}
------------------------------------------

To the best of our knowledge, this is the first study to evaluate the value of acoustic profile on prediction of origin of ventricular arrhythmia. With LBBB the S1 tends to be of reduced intensity as shown in a previous study^[@CR6]^. The reduced intensity of the S1 in LBBB is caused mainly by the decreased amplitude of the mitral valve excursion at the onset of left ventricular contraction. In our study, LBBB morphology PVC (RV origin) demonstrated non-significant reduced intensity, decreased complexity and shortened S1 slitting duration. Our result echoed the previous findings that reduced complexity and splitting duration of S1 in PVC with RV origin is caused mainly by the decreased amplitude of the mitral valve excursion at the onset of LV contraction and the decreased tension on the closed mitral valve resulting from the slow rate of LV pressure rise at the onset of the S1^[@CR16]^.

In our study population, 4 patients had left ventricular outflow tract (LVOT) VAs with LBBB morphology. This finding suggested that the acoustic parameter might provide better predictive value than traditional Holter with 3 ECG channels.

With RBBB the S1 tends to be widely spitted with a preserved amplitude and a larger late component. as shown in a previous study^[@CR7],[@CR8]^. In this study, RBBB morphology PVC (LV origin) was characterized by increased S1 duration and complexity, which were compatible with previous findings.

Acoustic profile and electrophysiology {#Sec18}
--------------------------------------

The acoustic profiles of S1 and S2 during sinus rhythm didn't significantly differ between Group 1 and Group 2. It is well understood that the intensity of precordial heart sounds is influenced by anatomic factors such as body surface area, characteristics of the thoracic cage and cardiac axis^[@CR17]^. To eliminate the individual anatomic difference, we also evaluated the difference of acoustic profiles between PVC and SR beats. We observed that the complexity and splitting duration of S1 were significantly increased in left side PVCs compared to that in SR. Reversely, reduced complexity and splitting duration of S1 were found in right side PVCs compared to that in sinus beats. The difference of PVC and SR (PVC-SR) in S1 duration was shown to be a better parameter in differentiating VA origin.

To the best of our knowledge, there was no study to evaluate the acoustic difference between OT-VA and non-OT VAs. Our presented study demonstrates that the OT-VA and non-OT VA had different acoustic parameter as S1 intensity in LV VA and S2 duration and S2 complexity in RV VA. Further prospective studies with systemic approaches are warranted to prove this finding.

The mechanism of ΔS1 duration {#Sec19}
-----------------------------

The S1 is produced by vibrations generated by the closure of the mitral and the tricuspid valves. There is normal asynchrony in the closure of mitral and tricuspid valves, the mitral closure preceding tricuspid closure by 20 to 30 msec^[@CR18]^. Ventricular ectopy from LV activated LV myocardium and initiate mitral valve closure first. Late onset of RV contraction secondary to a mean 25.7 msec transeptal conduction time^[@CR19]^ contributed to the prolonged S1 during LV PVC, which was caused by delayed onset of the right ventricular pressure pulse and tricuspid closure. Our present study demonstrated a positive change of S1 splitting duration of LV PVC in comparison to SR, which echoed the previous concept of hemodynamic and electrophysiological aspects.

In the previous study, the atrioventricular valve closure times during LBBB morphology beats^[@CR6]^, mitral valve closure occurred earlier than tricuspid valve in 27% of the subjects. Some hemodynamic studies have been conducted to determine the delay in onset of left ventricular contraction in LBBB morphology beats and the reversed splitting was not consistently observed on the phonocardiograms^[@CR20]--[@CR22]^. Our present study revealed a negative change of S1 duration with large standard deviation (−18.66 ± 11.78 ms) of RV PVC in comparison to SR beats, which echoed the previous reports.

In view of electrophysiological hemodynamic points, the LV PVC exaggerated the normal asynchrony through transseptal conduction time. On the other hand, the RV PVC shortened or reversed the naturally splitting sequence of atrioventricular valve closure and produced a relatively negative change of S1 during comparing to LV PVCs.

Clinical implication {#Sec20}
--------------------

Conventional Holter examination could only provide the information regarding the presence of arrhythmia. In addition to the ECG strip, the acoustic cardiography was automatically analyzed for the measurement of heart sound parameters, which effectively provided the information of potential VA origin. The acoustic cardiographic examination can be used to determinate the dominant PVC origin with our documented 12-lead ECG or symptomatic PVC origin and guide the clinical decision making before and during interventional electrophysiologic procedures. After successful ablation, the acoustic cardiography could provide the information regarding the pattern of recurrence (same origin or not). Before our present study, invasive electrophysiological study and 12 leads surface ECG were the only clinically available methodology in determining VA origin. The clinical value of conventional ECG was limited by the short recording time (10 seconds strip with 2.5 seconds in each lead). The acoustic cardiography not only provided the information of the presence of arrhythmia but also the origin of ventricular ectopic beats. Based on this additional information, clinician can be informed of the potential benefit and procedure related complication in detail.

Limitations {#Sec21}
===========

Several limitations merit consideration. First, the sample size was relatively small, which provided a weak power for the generalization of the conclusion. We adjusted for possible inter-subject anthropomorphic differences by calculating the difference between PVC and SR beats. Second, this study is limited by its retrospective nature. Third, although it's clinical value has been established in previous literatures, acoustic cardiography is easily affected by environmental interference. Carefully review and manual editing by experienced technician were required. Fourth, although the change of S1 complexity, and S1 splitting duration displayed potential predictive utility for the discrimination of VA origin, the study cohort was preselected to elucidate the physiological underpinnings of transmitted heart sounds, and thus patients with valvular abnormalities and conduction disorders were excluded. Fifth, the clinical value of acoustic cardiography for VA in the patients with structural heart disease or valvular heart disease was not clear because of the study design. Additionally, this present study included patients with distinctive VA origin from RV and LV. Various impact of activation wavefront might affect our observation on the heart sound change. Further prospective trial with different cohort and larger samples is warranted for validation and confirmation.

Conclusion {#Sec22}
==========

The difference of S1 splitting duration between SR and PVC could accurately predict the chamber of VA origin. Further acoustic analysis might help differentiate the OT VA and non-OT VA. Increased PVC S1 duration compared to that of SR beats was altered in the left side VA group. In the group with LV VA, OT origin VA was presented with negative change in S1 intensity during PVC. In the RV VA, OT origin VA was presented with positive change in S1 intensity during PVC. These findings extend our mechanistic understanding of the relationship between ventricular arrhythmia and the precordial acoustic profile. Further prospective study is warranted for applying the acoustic data in differentiating the location of VA.
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